NextCure, Inc. (NXTC) Corporate Subsidiaries
NextCure, Inc. (NXTC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NXTC
CIK: 1661059
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerThomas Sand
Audit LocationBaltimore, Maryland, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-4/A | 2026-10-01 | — | S-4/A | 0001104659-26-112469 | View SEC Doc Filr Page |
| 425 | 2026-09-25 | — | 425 | 0001104659-26-110975 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-21 | 8-K | 0001104659-26-110971 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001104659-26-105057 | View SEC Doc Filr Page |
| S-4 | 2026-08-18 | — | S-4 | 0001104659-26-098412 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097427 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352946 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0002050709-26-000024 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001011438-26-000507 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0000919574-26-004977 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0001213900-26-088156 | View SEC Doc Filr Page |
| 425 | 2026-08-10 | — | 425 | 0001104659-26-093342 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-092050 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001104659-26-092025 | View SEC Doc Filr Page |
| 425 | 2026-08-04 | — | 425 | 0001104659-26-090069 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | PRIMARY DOCUMENT | 0001940272-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | PRIMARY DOCUMENT | 0001940272-26-000012 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-27 | PRIMARY DOCUMENT | 0001940272-26-000011 | View SEC Doc Filr Page |
| 425 | 2026-07-16 | — | 425 | 0001104659-26-084319 | View SEC Doc Filr Page |
| 425 | 2026-07-14 | — | 425 | 0001104659-26-083327 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-14 | FORM 8-K | 0001104659-26-083326 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-18 | 8-K | 0001104659-26-077546 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0000905148-26-003047 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0000905148-26-003045 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0000905148-26-003048 | View SEC Doc Filr Page |